Lancome Paris Teint Idole Ultra Wear Care And Glow Skincare Foundation Broad Spectrum Spf 27 Sunscreen Liquid
NDC Package 51150-207-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Lancome Paris Teint Idole Ultra Wear Care And Glow Skincare Foundation Broad Spectrum Spf 27 Sunscreen (ensulizole) liquids is for sunscreen use:●  shake well●  apply liberally 15 minutes before sun exposure● use a water resistant sunscreen if swimming or sweating● Sun Protection Measures. This formulation utilizes a liquid delivery system. Marketed by Sicos Et Cie, this product is identified by NDC 51150-207 and is authorized under FDA application M020.

Identification & Billing

NDC Package Code
51150-207-01
Package Description
1 BOTTLE, GLASS in 1 CARTON / 30 mL in 1 BOTTLE, GLASS
Product Code
51150-207
11-Digit Billing Format
51150020701

Clinical Specifications

Proprietary Name
Lancome Paris Teint Idole Ultra Wear Care And Glow Skincare Foundation Broad Spectrum Spf 27 Sunscreen
Non-Proprietary Name
Ensulizole
Substance Name
Ensulizole
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
ENSULIZOLE 36 mg/mL
Usage Information
For sunscreen use:●  shake well●  apply liberally 15 minutes before sun exposure● use a water resistant sunscreen if swimming or sweating● Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:      ● limit time in the sun, especially from 10 a.m. – 2 p.m.     ● wear long-sleeved shirts, pants, hats, and sunglasses● children under 6 months of age: Ask a doctor

Regulatory & Marketing

Labeler Name
Sicos Et Cie
Product Type
Human Otc Drug
FDA Application #
M020
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
05-27-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51150-207-01 identifies a specific commercial package of 1 bottle, glass in 1 carton / 30 ml in 1 bottle, glass of Lancome Paris Teint Idole Ultra Wear Care And Glow Skincare Foundation Broad Spectrum Spf 27 Sunscreen, a human over the counter drug labeled by Sicos Et Cie. This liquid is formulated for topical use and contains ensulizole as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sicos Et Cie on May 27, 2026. The current certification is valid through December 31, 2027.

How is this Sicos Et Cie product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51150020701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
51150-207-01
11-Digit CMS (5-4-2)
51150-0207-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.